Effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after PCI treatment in STEMI patients

被引:0
|
作者
Li, Guiru [1 ]
Yue, Dongmei [1 ]
机构
[1] Shanghai Univ Med & Hlth Sci, Affiliated Chongming Hosp, Dept Cardiol, Shanghai 202150, Peoples R China
关键词
STEMI; PCI; Ticagrelor; Nicorandil;
D O I
10.22514/sv.2024.147
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study investigated the effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). We retrospectively analyzed 300 STEMI patients who underwent emergency PCI, 150 in the observation group and 150 in the control group. The control group was given oral ticagrelor. The observation group received oral nicorandil along with the control group. A significant improvement in peak ejection rate (PER) and left ventricular (LV) ejection fraction (EF) occurred after the operation, while LV end-diastolic volume index (LVESVI), LV end-diastolic internal diameter (LVEDD), cardiac troponin I (cTnI), and creatine kinase myoglobin (CK-MB) were significantly reduced compared to the preoperative period. Improvements in cardiac function were significantly greater in the observation group than in the control group (p < 0.05). After the operation, both groups' serum nitric oxide (NO) and endothelin-1 (ET-1) levels were greatly higher and lower, respectively, during the preoperative period (p <0.05). The observation group's serum NO level was significantly higher than the control group's, and its ET-1 level was substantially lower than the control group's (p < 0.05). There was a significant increase in thrombolysis in myocardial infarction (TIMI) flow grade 3 percentage and TIMI myocardial perfusion grade (TMPG) grade 3 percentage in the observation group in the immediate postoperative period compared to the control group, despite a significantly lower corrected TIMI Frame count (CTFC) (p < 0.05). 1 month postoperatively, major adverse cardiovascular events (MACE) incidence was significantly lower in the observation group than in the control group (chi(2) = 3.914, p = 0.048). The preoperative combination of ticagrelor and nicorandil in STEMI patients undergoing PCI helped attenuate vascular endothelial function impairment, improved coronary blood flow, and promoted postoperative cardiac function recovery.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [31] Effect of the therapy of amiodarone combined with atorvastatin on cardiac function of patients with acute myocardial infarction after percutaneous coronary intervention (PCI)
    Tu, Yanming
    Zhang, Jingyi
    Zhang, Ming
    Li, Zhiyong
    Zong, Wenxia
    Zhou, Qiyu
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (05) : 2035 - 2040
  • [32] Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI
    Cakmak, Tolga
    Yasar, Erdogan
    Cakmak, Esin
    Tekin, Suat
    Karakus, Yasin
    Turkoglu, Caner
    Yuksel, Furkan
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (01)
  • [33] THE ASSOCIATION OF SERUM URIC ACID LEVELS WITH CORONARY FLOW IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI
    Akpek, M.
    Kaya, M. G.
    Uyarel, H.
    Yarlioglues, M.
    Gunebakmaz, O.
    Elcik, D.
    Sahin, O.
    Dogdu, O.
    Ardic, I.
    Oguzhan, A.
    Ergin, A.
    Gibson, C. M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S88 - S88
  • [34] The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI
    Akpek, Mahmut
    Kaya, Mehmet G.
    Uyarel, Huseyin
    Yarlioglues, Mikail
    Kalay, Nihat
    Gunebakmaz, Ozgur
    Dogdu, Orhan
    Ardic, Idris
    Elcik, Deniz
    Sahin, Omer
    Oguzhan, Abdurrahman
    Ergin, Ali
    Gibson, Charles M.
    ATHEROSCLEROSIS, 2011, 219 (01) : 334 - 341
  • [35] The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI
    Akpek, M.
    Uyarel, H.
    Yarlioglues, M.
    Kalay, N.
    Gunebakmaz, O.
    Dogdu, O.
    Ardic, I.
    Sahin, O.
    Oguzhan, A.
    Kaya, M. G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 629 - 629
  • [36] Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
    Zhe Wang
    Da-Yan Zhou
    Yong Su
    Liang-Yi Si
    Qiang Xu
    BMC Cardiovascular Disorders, 20
  • [37] The effects of nicorandil on microcirculation of coronary artery and short-term prognosis in patients with STEMI after primary percutaneous coronary intervention
    Peng, Wenjin
    Liu, Yingwu
    Cong, Hongliang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C176 - C176
  • [38] Observation of the effect of interventional therapy combined with nicorandil in patients with coronary heart disease and angina pectoris and its effect on cardiac function
    Zhou, Gang
    Gong, Qian
    Wang, Hu
    Wang, Min
    Dai, Min
    Luo, Caidong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 108 - 108
  • [39] Left ventricular function recovery after hyperoxemic blood infusion in STEMI treated with primary PCI
    Ettori, F
    Niccoli, L
    Curello, S
    Leonzi, O
    Chizzola, G
    Valgimigli, M
    Gobbi, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 117L - 117L
  • [40] The Effect of Ticagrelor on Cardiopulmonary Function in Patients With Stable Coronary Artery Disease
    Storey, Robert F.
    Bliden, Kevin
    Patil, Shankar B.
    Karunakaran, Arun
    Ecob, Rosemary
    Butler, Kathleen
    Teng, Renli
    Gurbel, Paul
    CIRCULATION, 2009, 120 (18) : S1145 - S1145